RVMD — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.37

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

0.35

EPS Last/This Y

-2.12

EPS This/Next Y

2.27

Price

205.27

Target Price

216.4

Analyst Recom

1.1

Performance Q

43.95

Upside

-250.3%

Beta

1.4

Ticker: RVMD

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	RVMD	183.86	0.47	0.11	81340
2026-07-14	RVMD	184.92	0.47	0.78	81151
2026-07-15	RVMD	184.57	0.48	8.48	82037
2026-07-16	RVMD	179.28	0.48	0.26	82219
2026-07-17	RVMD	186.09	0.48	0.19	82383
2026-07-20	RVMD	181.15	0.52	0.30	65355
2026-07-21	RVMD	182.53	0.52	0.26	66034
2026-07-22	RVMD	182.96	0.51	0.58	66436
2026-07-23	RVMD	188.57	0.52	0.12	66573
2026-07-24	RVMD	189.16	0.50	0.14	67986
2026-07-27	RVMD	187.02	0.50	0.12	68405
2026-07-28	RVMD	184.02	0.49	0.88	68986
2026-07-29	RVMD	180.76	0.50	0.43	69512
2026-07-30	RVMD	192.1	0.51	0.24	69447
2026-07-31	RVMD	187.6	0.51	0.06	69504
2026-08-03	RVMD	182.43	0.50	0.40	69661
2026-08-04	RVMD	193.35	0.51	0.20	69863
2026-08-05	RVMD	197	0.51	0.20	70303
2026-08-06	RVMD	197.93	0.51	0.13	70654
2026-08-07	RVMD	204.23	0.55	0.37	67613
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	RVMD	183.85	-55.2	-	-8.04
2026-07-14	RVMD	184.94	-55.2	-	-8.04
2026-07-15	RVMD	184.43	-55.2	-	-8.04
2026-07-16	RVMD	179.13	-55.2	-	-8.04
2026-07-17	RVMD	186.08	-55.9	-	-8.03
2026-07-20	RVMD	180.39	-55.9	-	-8.03
2026-07-21	RVMD	183.28	-55.9	-	-8.03
2026-07-22	RVMD	182.99	-55.9	-	-8.02
2026-07-23	RVMD	188.75	-55.9	-	-8.02
2026-07-24	RVMD	189.11	-56.5	-	-8.06
2026-07-27	RVMD	188.18	-56.5	-	-8.06
2026-07-28	RVMD	183.86	-57.0	-	-8.07
2026-07-29	RVMD	180.87	-57.0	-	-8.07
2026-07-30	RVMD	191.96	-57.0	-	-8.07
2026-07-31	RVMD	187.59	-57.0	-	-8.07
2026-08-03	RVMD	182.27	-57.0	-	-8.07
2026-08-04	RVMD	182.27	-57.0	-	-8.07
2026-08-05	RVMD	196.96	-57.0	-	-8.07
2026-08-06	RVMD	197.81	-57.0	-	-8.07
2026-08-07	RVMD	205.27	-57.0	-	-8.07
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	RVMD	-1.68	-0.36	6.78
2026-07-14	RVMD	-1.68	-0.36	6.78
2026-07-15	RVMD	-1.68	-0.36	6.78
2026-07-16	RVMD	-1.68	-0.36	6.78
2026-07-17	RVMD	-1.68	-0.36	6.78
2026-07-20	RVMD	-1.68	-0.31	6.78
2026-07-21	RVMD	-1.68	-0.31	6.78
2026-07-22	RVMD	-1.68	-0.31	6.78
2026-07-23	RVMD	-1.68	-0.31	6.78
2026-07-24	RVMD	-1.68	-0.31	6.78
2026-07-27	RVMD	-1.68	-0.31	7.37
2026-07-28	RVMD	-1.68	-0.31	7.37
2026-07-29	RVMD	-1.68	-0.31	7.37
2026-07-30	RVMD	-1.68	-0.31	7.37
2026-07-31	RVMD	-1.68	-0.31	7.37
2026-08-03	RVMD	-1.68	0.24	7.37
2026-08-04	RVMD	-1.68	0.24	7.37
2026-08-05	RVMD	-1.68	0.24	7.37
2026-08-06	RVMD	-1.68	0.24	7.37
2026-08-07	RVMD	-1.68	0.24	7.37
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-2.34

Avg. EPS Est. Current Quarter

-2.06

Avg. EPS Est. Next Quarter

-1.99

Insider Transactions

-1.68

Institutional Transactions

0.24

Beta

1.4

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-1.1

Max Drawdown 5-Year %

-56.9

Target Price

216.4

P/E

Forward P/E

PEG

P/S

P/B

16.86

P/Free Cash Flow

EPS

-8.81

Average EPS Est. Cur. Y

-8.07

EPS Next Y. (Est.)

-5.8

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.63

Return on Equity vs Sector %

-95.2

Return on Equity vs Industry %

-79.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.06

EBIT Estimation

◆ RVMD Healthcare

$205.15

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

4/25

Volume

9/15

Valuation

2/20

TP/AR

4/10

Options

7/10

RSI

67.1

Range 1M

94.6%

Sup Dist

5.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

10/30

Estimates

4/20

Inst/Vol

6/15

Options

7/10

EPS Yr

-56%

EPS NY

27.9%

52W%

99.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +5.5% upside

Quality

2/30

Valuation

2/30

Growth

7/25

Stability

7/10

LT Trend

4/5

Upside

+5.5%

Quality

RVMD — P/E HistoricalBiotechnology

Revolution Medicines, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 883

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

RVMD

Latest News

—

Caricamento notizie per RVMD…

stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today

news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance

stock history RVMD – Revolution Medicines, Inc. invest stock market

stock prices RVMD premarket after hours

ticker RVMD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RVMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y